# Rentschler Biopharma SE - Inspection Records

Source: https://www.globalkeysolutions.net/companies/rentschler-biopharma-se/da50fa41-24f6-449f-bf90-45eccb97d9ba

> Inspection records and compliance data for Rentschler Biopharma SE in Baden-Wurttemberg, None. Access full analysis and detailed observations.

---

## Details

- Name: Rentschler Biopharma SE
- FEI Number: 1000291122
- City: Baden-Wurttemberg
- State: None
- Country Name: Germany
- Address Line 1: Erwin-Rentschler-Str. 21
- Address Line 2: Laupheim
- Zip Code: None
- Facility Type: Drug Substance Intermediate Manufacturer

## Related Documents

- [FDA Inspection 1246782 - Rentschler Biopharma SE - 2023-05-05](https://www.globalkeysolutions.net/records/fda_inspections/rentschler-biopharma-se/0d912736-9230-4aef-96a6-874067c47f8c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 5, 2023
- [483 - Rentschler Biopharma SE - 2023-03-07](https://www.globalkeysolutions.net/records/483/rentschler-biopharma-se/a389d15c-79c7-4e86-8ab6-bab16b1db149) — source: FDA, date: March 7, 2023
- [483 - Rentschler Biopharma SE - 2023-03-07](https://www.globalkeysolutions.net/records/483/rentschler-biopharma-se/a356438e-6da6-487c-a025-d6d0b1b6c608) — source: FDA, date: March 7, 2023
- [483 - Rentschler Biopharma SE - 2022-02-15](https://www.globalkeysolutions.net/records/483/rentschler-biopharma-se/3d74a8dd-3407-4ca5-8531-86e86b20f52c) — source: FDA, date: February 15, 2022
- [EIR - Rentschler Biopharma SE - 2022-02-15](https://www.globalkeysolutions.net/records/eir/rentschler-biopharma-se/d3900ca0-3215-45e5-b136-19fb4ba548b9) — source: FDA, date: February 15, 2022
- [483 - Rentschler Biopharma SE - 2022-02-15](https://www.globalkeysolutions.net/records/483/rentschler-biopharma-se/dd46571c-c83f-449f-a4c7-b1b10e214eae) — source: FDA, date: February 15, 2022
- [FDA Inspection 1160831 - Rentschler Biopharma SE - 2021-02-26](https://www.globalkeysolutions.net/records/fda_inspections/rentschler-biopharma-se/5c3bee2b-f543-44ea-878b-b0b820cae70f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 26, 2021
- [FDA Inspection 1102650 - Rentschler Biopharma SE - 2019-08-09](https://www.globalkeysolutions.net/records/fda_inspections/rentschler-biopharma-se/41551671-1c8f-41a7-8269-faa6cb1760fb) — classification: No Action Indicated (NAI), source: FDA, date: August 9, 2019
- [FDA Inspection 999800 - Rentschler Biopharma SE - 2016-12-06](https://www.globalkeysolutions.net/records/fda_inspections/rentschler-biopharma-se/fd3c2655-b57f-4166-9399-c3a17930da99) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 6, 2016
- [FDA Inspection 933400 - Rentschler Biopharma SE - 2015-06-16](https://www.globalkeysolutions.net/records/fda_inspections/rentschler-biopharma-se/72b19de5-5f32-4b03-9fbb-09b85a00b404) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 16, 2015
- [FDA Inspection 853179 - Rentschler Biopharma SE - 2013-09-20](https://www.globalkeysolutions.net/records/fda_inspections/rentschler-biopharma-se/6d4b4198-45a4-431a-ba15-bbc0d85ac1b2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 20, 2013
- [FDA Inspection 744719 - Rentschler Biopharma SE - 2011-07-19](https://www.globalkeysolutions.net/records/fda_inspections/rentschler-biopharma-se/19c5afbb-6679-47b2-bdc7-0cce2b3a7eb9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 19, 2011

## Related Companies

- [Chugai Pharma Manufacturing Co. Ltd.](https://www.globalkeysolutions.net/companies/chugai-pharma-manufacturing-co-ltd/09ba6515-9227-444c-a24c-a6cb8da9e235)
- [Purolea Cosmetics Lab](https://www.globalkeysolutions.net/companies/purolea-cosmetics-lab/a2662a80-cd8c-4da0-bd8d-6cd4ea6079c6)
- [Takeda Manufacturing Italia SPA](https://www.globalkeysolutions.net/companies/takeda-manufacturing-italia-spa/1998fa46-5f10-426b-b959-5378f2b887e1)
- [KBI Biopharma, Inc.](https://www.globalkeysolutions.net/companies/kbi-biopharma-inc/c19eb9d6-d05c-437c-b018-992dba71d288)
- [Regeneron Pharmaceuticals Inc](https://www.globalkeysolutions.net/companies/regeneron-pharmaceuticals-inc/cd765cfa-95e6-4023-ade2-0ffa382fe2c7)
- [Wyeth Pharmaceutical Division of Wyeth Holdings LLC](https://www.globalkeysolutions.net/companies/wyeth-pharmaceutical-division-of-wyeth-holdings-llc/85fd73c7-1b97-4ac5-bc70-53dfb31c37e5)
- [Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.](https://www.globalkeysolutions.net/companies/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/d07820ec-a994-41cb-b667-509183a6cc4a)
- [Genzyme Corporation](https://www.globalkeysolutions.net/companies/genzyme-corporation/b597b205-d758-426b-bc64-09970b3a1b83)
- [BSP Pharmaceuticals SpA](https://www.globalkeysolutions.net/companies/bsp-pharmaceuticals-spa/cbf52ec3-50e2-4cf1-9f81-f0f7a74473fc)
- [Hovione LLC](https://www.globalkeysolutions.net/companies/hovione-llc/06b4417a-5377-4e73-8076-71d3066fa8f0)

## Related Officers

- [Ralph M. Bernstein](https://www.globalkeysolutions.net/people/ralph-m-bernstein/72173dfb-24ae-42a1-af9e-1dc7da02ed87)
- [Quality System Specialist](https://www.globalkeysolutions.net/people/jose-e-melendez/75bd6083-14a4-4bd2-a0e5-9946d4dd37e1)
- [ Investigator, Consumer Safety Officer](https://www.globalkeysolutions.net/people/thuy-t-nguyen/1cfb5467-f0b7-49b8-85c1-00373692e35e)